WHITNEY ROLLER: Open Payments
NPI 1083315741 · KIRKSVILLE, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$194 in 12 payments from 8 companies in 2025. Trend: 2023 $155 · 2024 $263 · 2025 $194
Food & beverage: $194
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 3 | $58 |
| Lundbeck LLC | 2 | $33 |
| Kowa Pharmaceuticals America, Inc. | 2 | $28 |
| Ardelyx, Inc. | 1 | $19 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $15 |
| Merck Sharp & Dohme LLC | 1 | $14 |
| Grifols USA, LLC | 1 | $14 |
| GlaxoSmithKline, LLC. | 1 | $14 |
Products named: LEQVIO, REXULTI, ZORYVE, IBSRELA, CAPLYTA, M-M-R II, Prolastin-C Liquid, AREXVY.
Industry payments across MO — which companies pay providers there.
